
Corporate Communications
Latest News
Advertisement
Latest Videos

Shorts
Advertisement
More News

Strategic alignment combines data-driven intelligence with pharma and biotech commercialization to support an integrated platform for healthcare and life sciences brands.

“This is about building a powerful bridge between the science that transforms lives and the systems that deliver that transformation,” said Michael J. Hennessy Jr., MJH Life Sciences chairman and CEO, of the BPD Healthcare acquisition.

A monthly roundup of business and people news in the pharmaceutical industry.

Legos will take over from Roger Dansey, who will begin transitioning to retirement.
Advertisement
Advertisement
Trending on PharmExec
1
Keeping Human Expertise at the Center of AI
2
Pfizer, Verismo Strike Licensing Deals to Push CAR T Manufacturing In Vivo
3
Build, Buy, or Rent: Moving AI Beyond the Pilot Stage
4
Gilead Signs Royalty-Free Licensing Deals to Broaden Access to Obeldesivir
5







